Orchestra BioMed Holdings, Inc. Quarterly Debt-to-equity in % from Q2 2021 to Q1 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Orchestra BioMed Holdings, Inc. quarterly Debt-to-equity history and growth rate from Q2 2021 to Q1 2023.
  • Orchestra BioMed Holdings, Inc. Debt-to-equity for the quarter ending March 31, 2023 was 66.2 %.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2023 66.2 +151 Mar 31, 2023
Q4 2022 152 +226 Dec 31, 2022
Q3 2022 -81.9 +73.1 +47.2% Sep 30, 2022
Q2 2022 -83.7 +75 +47.3% Jun 30, 2022
Q1 2022 -84.9 Mar 31, 2022
Q4 2021 -74.3 Dec 31, 2021
Q3 2021 -155 Sep 30, 2021
Q2 2021 -159 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.